Source: Annual Congress 2012 - The latest insights in integrated care
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Hanada, N. Sakamoto, Y. Ishimatsu, T. Kakugawa, R. Kozu, H. Senjyu, S. Kohno (Nagasaki, Japan). The effect of corticosteroid use on skeletal muscle function in patients with interstitial lung disease. Eur Respir J 2012; 40: Suppl. 56, 638

Member's Comments

No comment yet.

Related content which might interest you: Corticosteroids affect skeletal muscle strength in mild level of breathlessness of patients with interstitial lung disease Source: Virtual Congress 2020 – Diagnostic and prognostic markers for disease-associated interstitial lung disease and hypersensitivity pneumonitis Year: 2020 The impact of an acute exacerbation on physical activity and skeletal muscle force in patients with cystic fibrosis Source: Annual Congress 2009 - Physiotherapy aspects in cystic fibrosis and functional assessment Year: 2009 Characteristics of peripheral muscle strength in patients with interstitial lung disease Source: Virtual Congress 2020 – Exercise tolerance and functional status across respiratory diseases Year: 2020 Relationship between the tissue depletion pattern and muscle mass, muscle strength and inflammation in COPD patients Source: Annual Congress 2006 - COPD and systemic inflammation Year: 2006 Beyond the lungs in fibrotic interstitial lung disease: does supplemental O2 improve skeletal muscle oxygenation and fatigue? Source: Virtual Congress 2020 – Exploring respiratory function Year: 2020 The effect of COPD on muscle structure and function Source: Annual Congress 2006 - COPD: a systemic disease affecting the muscles Year: 2006 Role of soluble α-klotho on lung and skeletal muscle function in chronic obstructive pulmonary disease Source: International Congress 2016 – Recent high impact findings regarding COPD comorbidities Year: 2016 Respiratory muscle function in interstitial lung disease Source: Eur Respir J 2013; 42: 211-219 Year: 2013 The effect of inspiratory muscle training in interstitial lung diseases Source: Virtual Congress 2020 – Reviews and novel insights into pulmonary rehabilitation Year: 2020 The effect of exercise in the patients with the diagnosis of interstitial lung fibrosis Source: Eur Respir J 2006; 28: Suppl. 50, 372s Year: 2006 Effect of pulmonary rehabilitation on systemic inflammatory markers, muscle cross section area and functional parameters in interstitial lung disease Source: Annual Congress 2012 - New issues in pulmonary function Year: 2012 Cardiac muscle mass and function are associated with altered body composition in patients with COPD Source: Annual Congress 2007 - Impact of comorbidities in pulmonary rehabilitation Year: 2007 Short-term dynamic lung function and predictors of lung function decline in systemic sclerosis-related interstitial lung disease Source: Virtual Congress 2020 – Diagnostic and prognostic markers for disease-associated interstitial lung disease and hypersensitivity pneumonitis Year: 2020 Assessment of skeletal muscle fiber type distribution and morphometry in patients with COPD and chronic hypoxemia Source: Eur Respir J 2003; 22: Suppl. 45, 538s Year: 2003 Effect of use of immunosuppressive drugs in peripheral and respiratory muscle strength in patients undergoing kidney transplantation Source: Annual Congress 2013 –Assessment methods involved in the physiotherapy treatment in different patient populations Year: 2013 Impact of comorbidities on the deterioration of skeletal muscle dysfunction among COPD patients Source: Virtual Congress 2020 – The multiple facets of pulmonary rehabilitation and chronic respiratory care Year: 2020 COPD patients with skeletal muscle dysfunction VS patients without impairment of skeletal muscle. Comparing features of COPD and life quality. Source: International Congress 2019 – Comorbidities in COPD and asthma: body composition and diabetes Year: 2019 Benefit of treatment with pirfenidone (PFD) persists over time in patients with idiopathic pulmonary fibrosis (IPF) with limited lung function impairment Source: International Congress 2016 – IPF treatment I Year: 2016 The impact of systemic corticosteroids on respiratory muscle function in severe asthma Source: Eur Respir J 2005; 26: Suppl. 49, 505s Year: 2005